Literature DB >> 6272695

Antiserum against the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase. Reactivity towards various protein kinases.

G Schwoch, A Hamann, H Hilz.   

Abstract

An antiserum against the catalytic subunit C of cyclic AMP-dependent protein kinase, isolated from bovine heart type II protein kinase, was produced in rabbits. Reaction of the catalytic subunit with antiserum and separation of the immunoglobulin G fraction by Protein A-Sepharose quantitatively removed the enzyme from solutions. Comparative immunotitration of protein kinases showed that the amount of antiserum required to eliminate 50% of the enzymic activity was identical for pure catalytic subunit, and for holoenzymes type I and type II. The reactivity of the holoenzymes with the antiserum was identical in the absence or the presence of dissociating concentrations of cyclic AMP. Most of the holoenzyme (type II) remains intact when bound to the antibodies as shown by quantification of the regulatory subunit in the supernatant of the immunoprecipitate. Titration with the antibodies also revealed the presence of a cyclic AMP-independent histone kinase in bovine heart protein kinase I preparations obtained by DEAE-cellulose chromatography. Cyclic AMP-dependent protein kinase purified from the particulate fraction of bovine heart reacted with the antiserum to the same degree as the soluble enzyme, whereas two cyclic AMP-independent kinases separated from the particle fraction neither reacted with the antiserum nor influenced the reaction of the antibodies with the cyclic AMP-dependent protein kinase. Immunotitration of the protein kinase catalytic subunit C from rat liver revealed that the antibodies had rather similar reactivities towards the rat liver and the bovine heart enzyme. This points to a relatively high degree of homology of the catalytic subunit in mammalian tissues and species. Broad applicability of the antiserum to problems related to cyclic AMP-dependent protein kinases is thus indicated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6272695      PMCID: PMC1162325          DOI: 10.1042/bj1920223

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  On the question of translocation of heart cAMP-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Translocation of cytoplasmic protein kinase and cyclic adenosine monophosphate-binding protein to intracellular acceptor sites.

Authors:  R A Jungmann; S Lee; A B DeAngelo
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

Review 3.  Protein kinases and protein kinase substrates.

Authors:  T A Langan
Journal:  Adv Cyclic Nucleotide Res       Date:  1973

4.  Assay of cyclic AMP-dependent protein kinases.

Authors:  J D Corbin; E M Reimann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

5.  Preparation of homogeneous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle.

Authors:  J A Beavo; P J Bechtel; E G Krebs
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

6.  Catlysis of the phosphrylaseinase actition reaction.

Authors:  D A Walsh; J P Perkins; C O Brosom; E S Ho; E G Kreb
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity.

Authors:  I M Glynn; J B Chappell
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

10.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  12 in total

1.  Rapid polymerization of LR-white for immunocytochemistry.

Authors:  S Hillmer; S Joachim; D G Robinson
Journal:  Histochemistry       Date:  1991

2.  Localization of catalytic and regulatory subunits of cyclic AMP-dependent protein kinases in mitochondria from various rat tissues.

Authors:  G Schwoch; B Trinczek; C Bode
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

3.  Selective regulation of the amount of catalytic subunit of cyclic AMP-dependent protein kinases during isoprenaline-induced growth of the rat parotid gland.

Authors:  G Schwoch
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

4.  Transcription factors in neuroendocrine regulation: rhythmic changes in pCREB and ICER levels frame melatonin synthesis.

Authors:  E Maronde; M Pfeffer; J Olcese; C A Molina; F Schlotter; F Dehghani; H W Korf; J H Stehle
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

5.  Determination and comparative analysis of the catalytic subunit of adenosine 3',5'-cyclic phosphate-dependent protein kinase by an enzyme-linked immunosorbent assay.

Authors:  G Schwoch; A Hamann
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

6.  Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists.

Authors:  R Van Buskirk; T Corcoran; J A Wagner
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

7.  Modulation of nuclear cyclic AMP-dependent protein kinase in dibutyryl cyclic AMP-treated rat H4IIE hepatoma cells.

Authors:  S P Squinto; R A Jungmann
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

8.  Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus.

Authors:  E A Nigg; H Hilz; H M Eppenberger; F Dutly
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

9.  Dibutyryl cAMP treatment of neuroblastoma-glioma hybrid cells results in selective increase in cAMP-receptor protein (R-I) as measured by monospecific antibodies.

Authors:  S M Lohmann; G Schwoch; G Reiser; R Port; U Walter
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Localization of nuclear subunits of cyclic AMP-dependent protein kinase by the immunocolloidal gold method.

Authors:  M R Kuettel; S P Squinto; J Kwast-Welfeld; G Schwoch; J S Schweppe; R A Jungmann
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.